Picture of Telesis Bio logo

TBIO — Telesis Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Telesis Bio Inc expected to post a loss of 23 cents a share - Earnings Preview

* Telesis Bio Inc  TBIO.OQ   TBIO.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 10 (estimated)
for the period ending March 31 2024
    * The San Diego California-based  company is expected to
report a
9.2% increase in revenue to $6.9 million from $6.32 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Telesis Bio Inc is for a
loss
of 23 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated May 8 at 12:56 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Telesis Bio

See all news